2024-09-21 - Analysis Report
## Gilead Sciences Inc (GILD) Stock Analysis

This report provides a comprehensive analysis of Gilead Sciences Inc (GILD), a biopharmaceutical company that develops and commercializes medicines for a wide range of medical conditions. 

**1. Performance and Relative Strength**

* **Cumulative Return:** GILD has underperformed significantly compared to the S&P 500 (VOO) with a cumulative return of **-12.54%** compared to **133.16%** for VOO. 
* **Relative Performance:** The current relative strength of GILD against VOO is **-145.7**, indicating a substantial underperformance. This places GILD at the **6.26th percentile** of its historical performance range against VOO. 

**2. Recent Price Movement**

* **Closing Price:** $84.33
* **5-Day Moving Average:** $83.47
* **20-Day Moving Average:** $80.1
* **60-Day Moving Average:** $75.11

The stock price is currently above all moving averages, suggesting potential upward momentum. 

**3. Technical Indicators**

* **RSI:** 75.74: This indicates the stock is currently in **overbought territory**, suggesting potential for a correction in the near term.
* **PPO:** 0.34: This shows a bullish signal, with the PPO indicator being above zero.
* **Delta_Previous_Relative_Divergence:** 2.39 (+): This suggests a potential short-term **upward trend** in relative performance. 
* **Expected Return:** 18.4%: This indicates a **potential for significant returns** over the next 5-10 years, based on current investment levels.

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 1.29 | 6.95 B$ |
| 2024-05-08 | -3.34 | 6.69 B$ |
| 2023-11-07 | 1.75 | 7.05 B$ |
| 2023-08-04 | 0.84 | 6.60 B$ |
| 2024-08-08 | 0.84 | 6.60 B$ |

The most recent earnings report for 2024-08-08 showed an EPS of 1.29 and revenue of 6.95 B$. This exceeded analyst expectations. 

**5. Overall Analysis**

While Gilead Sciences Inc (GILD) has faced challenges in recent years, its most recent earnings have demonstrated a strong rebound. The stock is currently above its moving averages, indicating potential for further upward movement. However, technical indicators suggest overbought conditions, requiring caution. The positive Delta_Previous_Relative_Divergence suggests a potential short-term upward trend in relative performance, while the Expected Return of 18.4% indicates long-term growth potential. 

**6. Conclusion**

GILD's performance is showing positive signs, but further analysis is needed to assess the sustainability of this trend. The company's recent earnings beat expectations and show promising growth. However, investors should be cautious about the overbought conditions indicated by technical indicators. Overall, GILD presents a complex investment case with potential for both gains and losses. Investors should monitor the company's performance closely and conduct thorough research before making any investment decisions. 
